| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,142 |
14,173 |
$4.34M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,127 |
10,105 |
$3.84M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,044 |
13,411 |
$2.73M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,484 |
5,835 |
$971K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,546 |
4,159 |
$677K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
35,517 |
33,011 |
$641K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
6,160 |
5,084 |
$405K |
| A0425 |
Ground mileage, per statute mile |
12,066 |
8,846 |
$392K |
| 71045 |
Radiologic examination, chest; single view |
4,147 |
3,736 |
$283K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,278 |
538 |
$279K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,536 |
2,403 |
$272K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,982 |
3,572 |
$168K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
436 |
421 |
$151K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,033 |
824 |
$118K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,251 |
1,212 |
$96K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,937 |
2,860 |
$89K |
| 0240U |
|
604 |
582 |
$75K |
| 71046 |
Radiologic examination, chest; 2 views |
673 |
605 |
$58K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
772 |
640 |
$49K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
382 |
362 |
$44K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
252 |
212 |
$44K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,690 |
3,554 |
$33K |
| 70450 |
Computed tomography, head or brain; without contrast material |
241 |
217 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
388 |
370 |
$16K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
686 |
668 |
$15K |
| 87428 |
|
155 |
152 |
$14K |
| 76801 |
|
87 |
80 |
$12K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
246 |
215 |
$11K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
51 |
48 |
$9K |
| 97597 |
|
97 |
45 |
$8K |
| 80053 |
Comprehensive metabolic panel |
17,809 |
16,114 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
21,646 |
18,680 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,487 |
19,263 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
31 |
30 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
26 |
25 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
107 |
81 |
$4K |
| 87400 |
|
2,013 |
1,002 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
182 |
178 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
75 |
71 |
$3K |
| 59025 |
Fetal non-stress test |
18 |
13 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
81 |
76 |
$2K |
| 80061 |
Lipid panel |
365 |
357 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
75 |
71 |
$2K |
| 87631 |
|
46 |
44 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
66 |
55 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12 |
12 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,366 |
8,085 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
751 |
725 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
16 |
$723.68 |
| 81001 |
|
4,568 |
4,173 |
$498.65 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,416 |
2,996 |
$483.27 |
| 81003 |
|
2,682 |
2,474 |
$415.30 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,174 |
1,099 |
$313.58 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,408 |
3,159 |
$223.32 |
| Q3014 |
Telehealth originating site facility fee |
13 |
12 |
$159.70 |
| 86850 |
|
12 |
12 |
$145.10 |
| 84484 |
|
5,292 |
3,842 |
$111.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,483 |
4,179 |
$101.16 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
17 |
17 |
$91.74 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
623 |
589 |
$84.37 |
| 82950 |
|
19 |
16 |
$83.55 |
| 83605 |
|
1,618 |
1,319 |
$49.91 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,256 |
1,001 |
$47.37 |
| 84703 |
|
1,443 |
1,337 |
$44.19 |
| 85027 |
|
369 |
341 |
$43.05 |
| 83690 |
|
3,100 |
2,851 |
$31.09 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,668 |
1,500 |
$25.81 |
| 86140 |
|
1,651 |
1,502 |
$25.64 |
| 82077 |
|
1,877 |
1,559 |
$16.41 |
| 80305 |
|
440 |
388 |
$14.35 |
| 87807 |
|
167 |
153 |
$14.06 |
| 85610 |
|
825 |
733 |
$5.48 |
| 83880 |
|
134 |
124 |
$4.90 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
15 |
13 |
$3.60 |
| 82962 |
|
105 |
87 |
$3.12 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
44 |
38 |
$1.62 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,953 |
1,762 |
$1.48 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
40 |
28 |
$0.02 |
| 84145 |
|
104 |
87 |
$0.00 |
| 80179 |
|
828 |
733 |
$0.00 |
| 80143 |
|
873 |
747 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
328 |
275 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
329 |
298 |
$0.00 |
| 84100 |
|
32 |
27 |
$0.00 |
| 84702 |
|
38 |
37 |
$0.00 |
| 83735 |
|
584 |
524 |
$0.00 |
| A9270 |
Non-covered item or service |
230 |
163 |
$0.00 |
| 87040 |
|
434 |
220 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
151 |
120 |
$0.00 |
| 85730 |
|
114 |
106 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
63 |
60 |
$0.00 |
| 82803 |
|
376 |
305 |
$0.00 |
| 85379 |
|
111 |
102 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
43 |
38 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
13 |
12 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17 |
17 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
28 |
27 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
13 |
13 |
$0.00 |
| 3044F |
|
16 |
13 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
16 |
13 |
$0.00 |